Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top New York based Director operating in the Health Care space. If you think a Director is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Joe Rubino
R&D Director of Reckitt
Follow Joe Rubino:
About Reckitt, Reckitt: Reckitt Benckiser Group is a consumer goods company makes health, hygiene and home products.
_______
Varun Gupta
IT Director, Advanced Analytics and Data Management of Mount Sinai Health System
Varun Gupta is a Technology executive with extensive IT Design, Strategy and Leadership experience in delivering business solutions to improve performance, reduce operational expenses and promote organizations growth. Focus areas include Information / Data Architecture and Strategy, Machine learning, Business Intelligence, Digital Solutions, Cloud Frameworks, Database Development and Implementation. Proficient in assisting organizations through Analytics and Digital transformations and setting up Big Data ecosystems and Advanced Analytics platforms for desired outcomes. Worked with Fortune 500 companies and has experience in leading and mentoring teams of Designers and Architects throughout the complete Software Development Life Cycle. Experienced in partnering with Data, Analytics and Digital technology vendors and Technology teams to evaluate Innovative solutions and build data infrastructure and solutions in a phased manner aligned with customers and the business needs. He is an expert in diverse Healthcare IT solution working for both Provider and Payer organizations. Proficient in leading large teams constituting Program managers, Technical Architects and Leads, database engineers and designers. Experienced in Designing state of the art Data as a service Frameworks via self-service API’s, Big Data on Hadoop ecosystem, citizen Business Intelligence solutions and Salesforce Platform. Varun has a bachelors in Computer Engineering and a Masters in Data science and Program Management from UCONN
Follow Varun Gupta:
About Mount Sinai Health System: The Mount Sinai Health System is an integrated health care system providing exceptional medical care to their local and global communities.
Lisa Chase
Senior Director of Marketing & Operations Strategy, Otolaryngology – Head , Neck Surgery of Mount Sinai Health System
Lisa Chase is the Senior Director of Marketing and Operations Strategy, Dept. of Otolaryngology at Mount Sinai Health System.
Follow Lisa Chase:
About Mount Sinai Health System: The Mount Sinai Health System is an integrated health care system providing exceptional medical care to their local and global communities.
Daniel Wilcox
Director of Member Care of Ro
Follow Daniel Wilcox:
About Ro: Ro is a telehealth startup that operates digital health clinics for men’s and women’s health, along with smoking cessation.
Eric Moskow
Chief Executive Officer, Director of Accuity Delivery Systems
Founder, CEO and Executive of several highly successful healthcare ventures; including DDDS, OBDS, and Cybear. Dr. Moskow is recognized as an innovative leader in the efficient operation of medical practices. He formed Outcome Based Delivery Systems, with operations in South Florida, Orlando, Florida and Las Vegas, Nevada, which OBDS sold in October 2011. From its founding in 2006 through the sale of its operations, OBDS built its revenue base from a run rate of $0 in 2006 to more than $80M in 2011. He formed Coral Gate Medical Group, a medical practice in Broward County, Florida, in January 2002 and has operated as its Managing Partner since inception. From 2002 to 2005, Coral Gate’s revenues increased from $350,000 to $3.5 million. From February 2000 through January 2002, Dr. Moskow served as Executive Vice President of Cybear, an information technology company serving the health care industry formed by Andrx Corp. He served as a Director of Cybear from June 1999 to 2002. From September 1996 to January 2000, Dr. Moskow was Executive Vice President of Strategic Planning for Phymatrix, a publicly-traded multi-specialty medical provider network. In addition, during this period and then through March 2002, he served as a Director of Phymatrix and its successor, Innovative Clinical Solutions, Ltd. (“ICSL”). From 1989 to 1997, Dr. Moskow served as an Internist and President of Family Medical Associates in Ridgefield, Connecticut. During part of this same period, from October 1995 to October 1996, Dr. Moskow served as Executive Vice President of Physician’s Choice Management, LLC (“PCM”), which he co-founded. In addition, from 1988 to 1992, Dr. Moskow served as Associate Medical Director in Connecticut for U.S. Healthcare. Dr. Moskow is board certified in internal medicine. He received his B.S. degree from Vassar College in 1980 and his M.D. degree from New York Medical College in 1984.
Follow Eric Moskow:
About Accuity Delivery Systems: Accuity Delivery Systems is a provider of clinical documentation services for the healthcare industry.
Jeremy Berger
Creative Director of Elysium
Follow Jeremy Berger:
About Elysium: Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs.
Vijay Raghavan
Senior Director, Management Science of Allergan
Follow Vijay Raghavan:
About Allergan: Allergan is a global pharmaceutical company.
Sylvana Quader Sinha
Founder, Managing Director and CEO of Praava Health
Sylvana Q. Sinha is founder and CEO of Praava Health, a leading healthcare company focused on improving health outcomes and patient journeys in emerging markets, where 85% of the world lives but whose current systems typically prioritize profits over patients.
Since launching in 2018, Praava has become Bangladesh’s fastest-growing consumer healthcare brand, and was designated a 2021 World Economic Forum Technology Pioneer and 2020 Fast Company World Changing Idea and Developing World Technology. Praava has served more than 300,000 patients and is tripling growth each year. Throughout the COVID-19 pandemic, Praava quadrupled its patient base while maintaining an NPS rating of 91.3—significantly exceeding even the highest scores of Fortune 500 companies.
Sylvana also has decades of experience leading teams in international law, business, development, and government relations at major international law firms, management consulting firms, the World Bank, and think tanks in the Middle East and S. Asia. In addition to serving as an advisor to then-Senator Obama, she has independently advised private and sovereign clients on investments, projects, and disputes in the Middle East, Africa, and S. Asia.
Sylvana is a Life Member of the Council on Foreign Relations, a member of the World Economic Forum’s UHC2030 Private Sector Constituency, and served on Mount Sinai’s Arnold Institute of Global Health Task Force for Global Advantage. She is a graduate of Columbia Law School, Harvard’s Kennedy School, and Wellesley College and was a Visiting Scholar at the University of Oxford.
Follow Sylvana Quader Sinha:
About Praava Health: Praava Health is a patient-driven company disrupting the healthcare standard for Bangladesh’s 170 million citizens.
Marie Auguste
Director of Materials Planning of Drive Medical
Marie Auguste joined Drive Medical in 2006 as Purchasing Manager. With over 20 years of experience in international business, Marie holds a Suny Maritime MBA in International Business and Trade. As a result of her leadership and dedication during the SAP implementation she was named Director or Materials Planning in 2009. Her primary responsibilities are not limited to but include data integrity, forecast and developing demand planning work processes in conjunction with Management & Commodity teams. Prior to joining Drive Marie held positions as a Production Manger for woven products at GAP International, and Purchasing Manager for Professional Audio products at Samson Technologies.
Follow Marie Auguste:
About Drive Medical, Premier: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Josiane Peluso
Director, Medicare Sales and Marketing of UnitedHealth Group
Josiane Peluso is an Executive Director with a fortune 500 company. She’s been with the company for eleven years starting as a Health Education Specialist, progressively moving into different positions. Josiane received her Bachelor’s degree in Health Promotions from St. Francis College and a Masters in Community Health From Brooklyn College.
Follow Josiane Peluso:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Melanie Raslan
Senior Director, Member Analytics and Reporting of UnitedHealth Group
Melanie Raslan is Director of Marketing Analytics at UnitedHealthcare Group.
Follow Melanie Raslan:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Ryan Loggie
Director of Accounting and Tax of OrbiMed
Follow Ryan Loggie:
About OrbiMed: OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
Amy Labroo
Director, Digital Marketing & OmniChannel of GSK
Follow Amy Labroo:
About GSK: GSK Venture Fund is a Massachusetts-based venture capital fund focused on investments within the area of bioelectronics.
Mindy Zhang
Director of Product Management of Oscar Health
Follow Mindy Zhang:
About First Round Fast Track, Oscar Health: Oscar is a health insurance company that offers individual and family plans, medicare advantages, and small group products.
Joshua Long
Director of Design of Oscar Health
Follow Joshua Long:
About Oscar Health: Oscar is a health insurance company that offers individual and family plans, medicare advantages, and small group products.
Mark Feuer
Independent Non-Executive Director of Constellation Healthcare Technologies
Feuer is the founding partner of Beechwood Capital Group, a private investment firm located in New York, which is focused on investments in the healthcare and insurance industries. Prior to forming Beechwood, Feuer most recently was Chief Executive Officer of Marsh USA. In previous roles he was also the Chief Operating Officer of Merrill Lynch Americas, with responsibility for the Trust Company, Retirement Division, Private Bank, and other operations. Feuer sat on the Product Development committee for the Global Wealth Management organisation. Feuer serves on several Boards of Directors, including many non-profit institutions in the New York area. He holds a Juris Doctor from New York Law School and an LLM in Taxation from New York University School of Law.
Follow Mark Feuer:
About : Constellation Healthcare Technologies provides a holistic, integrated suite of practice management support services to hospitals.
Snir Ben Shimol
Executive Director of Varonis Systems
Snir is the Head of Cyber Security at Varonis, leading the security research, forensics and incident response teams. Snir began his career in the IDF Technology and Intelligence unit and continued as a Security Researcher in the Israeli Prime Minister’s Office. Since then, he has worked in the Advanced Security Center of EY as the Cyber Security Advisory leader, managing red-team operations and risk assessments. He has advised major international corporates and high-profile individuals to build their security resilience and protect their organization. Prior to his current role, he led Radware’s Cyber Security Research division, responsible for innovation and security solution capabilities.
Follow Snir Ben Shimol:
About Varonis Systems: Varonis Systems provides actionable data governance solutions for financial services, healthcare, energy, manufacturing and tech companies.
Robert Sobers
Director of Inbound Marketing of Varonis Systems
Follow Robert Sobers:
About Varonis Systems: Varonis Systems provides actionable data governance solutions for financial services, healthcare, energy, manufacturing and tech companies.
Jason Klarreich
Managing Director, CFO, COO, & CCO of JW Asset Management
Jason Klarreich is the managing director, CFO, COO, and CCO at JW Asset Management. Before joining JWAM, Jason was a director and trader at Heartland Securities. He previously worked in fixed income sales at Morgan Stanley and at Smith Barney as a financial analyst in the asset management division. Jason serves on the board at Arbor Pharmaceuticals. He graduated from Emory University with a bachelor’s degree in finance.
Follow Jason Klarreich:
About JW Asset Management: JW Asset Management is a New York-based investment firm that primarily invests within the healthcare sector.
Andrew Schiff
Managing Director of Aisling Capital
Schiff joined Aisling in September of 1999 and currently serves as one of the Managing Partners. Prior to Aisling Capital, Dr. Schiff practiced internal medicine for six years at The New York Presbyterian Hospital, where he maintains his position as a Clinical Assistant Professor of Medicine. Dr. Schiff currently serves as a director of Agile Therapeutics, ARMGO Pharma, PowerVision and ZELTIQ Aesthetics. Prior Board service includes Adams Respiratory Therapeutics, ArgiNOx Pharmaceuticals, Barrier Therapeutics, Bioenvision, CardioKine, Cempra Pharmaceuticals, Miramar Labs, Myogen, SkinMedica, Sirion Therapeutics, TransEnterix and Quintiles (Board observer). He is a longtime supporter and Board member of the Visiting Nurse Service of New York. Dr. Schiff received his M.D. from Cornell University Medical College, his M.B.A. from Columbia University, and his B.S. with honors in Neuroscience from Brown University.
Follow Andrew Schiff:
About Aisling Capital: Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by
Jeffrey Gatz
Director of BioIVT
Jeffrey Gatz is the director at BioIVT.
Follow Jeffrey Gatz:
About : BioIVT is a worldwide provider of biological and in vitro products to pharmaceutical and biotechnology organizations
Sanjay Chadda
Partner & Managing Director of Petsky Prunier LLC
Sanjay Chadda runs one of the most active investment banking practices on Wall Street focused on the broader media, digital advertising and marketing, commerce, information and marketing technology and services industries. He has played an instrumental role in helping the firm become Bloomberg’s leading investment bank for mid-market internet & advertising transactions and has been named one of AlwaysOn’s “Power Players New York City” every year the honor has been awarded. As a trusted advisor to CEOs and private equity sponsors, Sanjay has led more than 70 transactions during his career and has successfully completed over 25 transactions since 2010 alone. In his engagements, he focuses on origination, due diligence, marketing, management, and negotiation of both M&A and private placement transactions in order to drive successful results for his clients. He is active in all of the firm’s industry practice areas and brings to his engagements a unique combination of extensive sell-side and buy-side M&A experience as well as a deep understanding of business models of companies in the sectors he covers. Sanjay has been a speaker at Strategy Institute’s Digital Out-of-Home Media Conference and the DMA Annual Leader’s Summit. He has also been a guest lecturer at New York University’s School of Continuing & Professional Studies Interactive and Direct Marketing Program. Prior to joining Petsky Prunier in 1999 he served as a financial analyst in GE Capital’s Financial Management Program. Sanjay holds a B.S. from the Charles F. Dolan School of Business at Fairfield University, where he graduated with honors.
Follow Sanjay Chadda:
About Petsky Prunier LLC, Petsky Prunier LLC: Leading investment bank to the technology, media, marketing, eCommerce, and healthcare industries.
Jason Shih
Director of Cinven
Jason Shih is a member of the Capital Markets team at Cinven and is based in New York. Prior to joining Cinven, Jason worked at Credit Suisse, where he was a Vice President within the Financial Sponsors Group in New York. Before this he worked at Berkeley Research Group in California as a Senior Associate. Jason holds an MBA from MIT Sloan School of Management and a B.A. Economics plus a B.S. Environmental Economics & Policy from the University of California, Berkeley. He joined Cinven in 2019.
Follow Jason Shih:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Raz Winiarsky
Co-Founder & Medical Director of Covera Health
Raz is a board-certified orthopedic surgeon, Medical Director at Brooklyn Premier Orthopedics, and Director of Joint Reconstruction at Hudson Regional Hospital. Raz received his M.D. degree from Albert Einstein College of Medicine, underwent his orthopedic surgical training at University of Pennsylvania, and completed his fellowship in Joint Reconstruction at Hospital for Special Surgery, rated by U.S. News as the #1 Orthopedic Hospital in the U.S. In addition to running one of the largest orthopedic groups in NYC, Raz is also a part-time chauffeur for his three children, transporting them to and from events all around the city.
Follow Raz Winiarsky:
About Covera Health: Covera Health is a provider of analytics-based programs intended to reduce medical misdiagnoses and improve quality of care.
Howard Yeh
Co-Founder, CEO & Board Director of HealthCare.com
Howard Yeh Online marketing entrepreneur and investor. President and Founder of HealthCare.com (Healthcare, Inc.). Founder of ContactUs.com, Inc. (2012), former co-founder of BrokersWeb (a 2x Inc 500 performance marketing company). Former venture capitalist at VantagePoint Capital Partners. Former investment banker at Merrill Lynch. Howard blogs at www.howardyeh.com.
Follow Howard Yeh:
About HealthCare.com: HealthCare.com is an insurtech platform that allows users to analyze health insurance options that are available in their area.
Alice Lin Fabiano
Global Director of Social Innovation & Investment, Global Community Impact of Johnson & Johnson
Alice Lin Fabiano is a Global Director at Johnson & Johnson, Global Community Impact. In this capacity, she leads its social innovation strategy and investments in the discovery, engagement, and celebration of purpose driven entrepreneurs, with a focus in health technology and impact investing.
Follow Alice Lin Fabiano:
About Johnson & Johnson, Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Susan Can
Senior Director & Global Corporate Brand and Corporate Affairs of Johnson & Johnson
Follow Susan Can:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Susan Can
Senior Director & Global Corporate Brand and Corporate Affairs of Johnson & Johnson
Follow Susan Can:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Gregory Smith
IT Director, I&AM Engineering of Johnson & Johnson
Follow Gregory Smith:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Omar Darwazah
Managing Director and General Partner of AAF Management Ltd.
Omar has over 16 years of international experience in corporate finance, strategy, investor relations and venture capital. He is a Managing Director and General Partner at AAF Management Ltd. (AAF), an early-stage venture capital firm he co-founded in 2016. AAF focuses on top tier venture-backed Seed and Series A investment opportunities in US-based startups that have international expansion potential and currently has over $100M in assets under management. AAF invests across Fintech, Consumer, Enterprise Software and Healthcare and its portfolio includes Synthego, Tamara Mellon, Current, Even Financial, Portfolium (acquired by Instructure), HeyDoctor (acquired by GoodRx), Prodigy (acquired by Upstart), TruOptik (acquired by Transunion) among others. Omar is also an angel investor in various technology companies including Andela, Blockstack and FiscalNote. He sits on the Board of the Middle East Investor Relations Association (MEIRA). He is also a mentor to the NYU Steinhardt EdTech Accelerator, an advisor to Yale University’s Center for Digital Health and Innovation and a judge at the Wharton School’s Venture Lab. Previously, Omar spent 10 years of his career with OCI N.V. in Cairo and New York focusing on strategy, corporate finance, and investor relations where he worked on over $35 billion worth of corporate transactions. Prior to that, he was with Deloitte in Chicago and Deutsche Bank’s Leveraged Finance team in London. Omar holds a BA in Economics and Political Science with Honors from the University of Chicago and an MBA from the Wharton School at the University of Pennsylvania. Omar was born in Cairo and lived in London, Chicago, Montreal and Paris. He now resides in New York City with his wife Bouchra and twin son and daughter Zayn and Layla. Omar enjoys scuba diving and is an avid travel photographer having visited 85 countries around the world. He also has an interest in film production and has been an Executive Producer on several short feature films including Baby Mine (2017) and Lab Rat (2018). He was named one of Wharton’s 40 Under 40 in 2017.
Follow Omar Darwazah:
About AAF Management Ltd., GoldCleats Global: AAF Management Ltd. is an early-stage VC firm focused on Seed and Series A technology companies.
Joe Echevarria
Board of Directors of Pfizer
Chief Executive Officer of Deloitte LLP, a global provider of professional services, from 2011 until his retirement in 2014. During his 36-year tenure with Deloitte, he served in various leadership roles, including Deputy Managing Partner, Southeast Region Audit Managing Partner and U.S. Managing Partner and Chief Operating Officer. Director of The Bank of New York Mellon Corporation. Member of the President’s Export Council and the Presidential Commission on Election Administration. Chair of President Obama’s My Brother’s Keeper Alliance. Member of the Board of Trustees of the University of Miami. Our Director since 2015. Member of our Audit, Regulatory and Compliance and Science and Technology Committees.
Follow Joe Echevarria:
About : Pfizer provides access to safe and effective and affordable medicines and health care services.
James Harnett
Senior Director, Real World Data & Analytics of Pfizer
Dr. James Harnett is a Senior Director in Real World Data and Analytics (RWDnA) for Pfizer’s Patient Health & Impact organization. Dr. Harnett has worked at Pfizer for over 15 years and supported establishing the RWDnA function. He was previously Team Lead in Outcomes Research and a Market Access Lead. He has conducted research across numerous therapeutic areas, currently focusing on oncology, vaccines, and inflammation & immunology, authoring over 30 peer-reviewed publications. Dr. Harnett has received awards for innovation on external partnerships and advanced analytics and use of real world evidence for regulatory decision making. He has a Doctor of Pharmacy degree and Master of Science degree in Clinical Epidemiology and Health Services Research.
Follow James Harnett:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Yael Gozin
Senior Director, Global Clininal Submissions Quality of Pfizer
Yael Gozin is a senior director at Pfizer, where she works with clinical development teams across Pfizer’s portfolio, which raised her interests in the use of technology to improve the processes and data quality associated with clinical development and regulatory submissions. Yael provides technical guidance both in designing and implementing innovative AI solutions to automate quality processes and coaching and mentoring of project teams across different therapeutic areas including oncology, innovative pharma, established products, and consumer products. She holds a doctorate from Swiss Federal Institute of Technology, Zurich (ETH Zurich) in organic chemistry and a master’s degree from the Weizmann Institute in organometallic chemistry.
Follow Yael Gozin:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Gerald Fetterly
Senior Director, Clinical Pharmacology of Pfizer
Dr. Gerald J. Fetterly is an Associate Professor of Oncology and the Director of the Pharmacokinetics and Pharmacodynamics Core Resource in the Department of Medicine at Roswell Park Cancer Institute. He is a clinical pharmacologist/pharmacokineticist who received his doctoral degree in Pharmaceutical Sciences from the University at Buffalo in 2000, where he has also been an Adjunct Assistant Professor since 2008. He possesses considerable expertise in developing oncology agents and the liposomal encapsulation of drugs. Specifically, his doctoral work and subsequent publications focused on an extensive assay development and comparison of the PK/PD relationships of various anticancer drugs, such as liposomal paclitaxel, trabectedin, and mTOR inhibitors. He has developed both preclinical and clinical PK/PD models to characterize the temporal relationship between the PK of the drug in relation to the time course of neutropenia and transaminase elevation. Prior to joining Roswell Park Cancer Institute, he worked at Cognigen to further his expertise in population PK/PD modeling to provide consulting services for both industry and academia to assess the impact of patient factors that are sources of variability in not only pharmacokinetics but also the PK/PD relationships for both efficacy and safety, mainly for oncology and neuropharmacology drugs. At Cognigen, he led and managed interdepartmental projects in Clinical Pharmacology, provided sparse sampling designs for clinical pharmacology trials, provided clinical pharmacology services for regulatory strategy during Advisory Board and Sponsor/FDA meetings, reviewed the non-clinical as well as clinical pharmacology development sections of various INDs and NDAs, as well as assisted in the interpretation of preclinical data and extrapolation of implications for human clinical development utilizing PK/PD modeling approaches. From 2000-2002, he was a clinical pharmacology and biopharmaceutics reviewer at the FDA. The experience of working with the agency has allowed him to supply insight to industry about the necessary components for a successful IND and NDA submission, along with guiding dose selection during the drug development process.
Follow Gerald Fetterly:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Stephen Kagan
Senior Director, Global Medical Affairs, Rare Disease of Pfizer
Follow Stephen Kagan:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Andrea Mancuso
Director, Training and Education Lead of Pfizer
Follow Andrea Mancuso:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
James Tornos
Senior Director Global Procurement of Pfizer
Follow James Tornos:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Steve Hammond
Director Process Analytical Support of Pfizer
Follow Steve Hammond:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Cal Austin
Director – Idea Sprint Lab of Pfizer
Follow Cal Austin:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Kelly Zou
Senior Director & Analytic Science Lead of Pfizer
Follow Kelly Zou:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Firelli Alonso
Senior Director, External Supply of Pfizer
Follow Firelli Alonso:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
William Fleder
Managing Director of Tailwind Capital
William Fleder is a Partner at Tailwind Capital
Follow William Fleder:
About Tailwind Capital: Tailwind focuses on growing middle market companies in the healthcare, business services, and media/communications sectors.
Alex Buzik
Managing Director of WindRose Health Investors
Mr. Buzik is a Managing Director of MTS and has more than 13 years of experience in healthcare private equity and investment banking. Mr. Buzik is responsible for sourcing, executing and managing healthcare private equity investments at MTS. Prior to joining MTS in 2005, Mr. Buzik worked as member of the Investment Banking Division at Lehman Brothers, where he focused on mergers and acquisitions as well as capital financings within the healthcare industry. Mr. Buzik currently serves on the board of directors of Aerocare, Data Driven Delivery Systems, Woodbury Health Products, HealthHelp, Ovagen Fertility and TrustHCS. Mr. Buzik formerly served on the board of directors of DNA Diagnostics Center and Florida Gulf-to-Bay Anesthesiology. Mr. Buzik received his Masters of Business Administration from The Wharton School at the University of Pennsylvania (majoring in Finance and Health Care Management) and his Bachelor of Arts in Biochemistry from Dartmouth College.
Follow Alex Buzik:
About WindRose Health Investors: WindRose Health Investors makes private equity investments in businesses that operate within the services sectors of healthcare.
Oliver Moses
Senior Managing Director of WindRose Health Investors
Mr. Moses has spent the last 21 years as a healthcare industry advisor and investor. Mr. Moses currently serves as the Senior Managing Director of MTS Health Investors, LLC, a New York-based private equity fund that focuses exclusively on healthcare. Prior to joining MTS in early 2006, Mr. Moses was a founding partner of MBF Healthcare Partners and previously, Mr. Moses was a Director in Merrill Lynch’s healthcare investment banking group. He joined Merrill Lynch in 1994 and was responsible for advising leading healthcare companies on mergers, acquisitions, and capital structure strategies. During his investment banking career, Mr. Moses raised $6.3 billion for his clients and advised on M&A transactions with an aggregate value of more than $16 billion. Prior to investment banking, Mr. Moses was a securities analyst in Merrill Lynch’s equity research department, where he provided coverage of companies in the healthcare services industry. In that role, he was ranked as one of Wall Street’s “Up and Comers” by Institutional Investor’s All-America Research Team Survey. Mr. Moses currently serves on the board of directors of AGS Health, HealthHelp, MDsave, myNEXUS, Woodbury Health Products and Vital Decisions. Mr. Moses is also involved in a number of charitable endeavors. He currently serves on the board of the African Dream Academy Foundation and as a deacon of The Brick Presbyterian Church. Mr. Moses holds a Bachelor of Arts degree from Bowdoin College.
Follow Oliver Moses:
About WindRose Health Investors: WindRose Health Investors makes private equity investments in businesses that operate within the services sectors of healthcare.
Paul Weaver
Board of Director of WellCare Health Plans
Weaver has over 30 years of experience in providing accounting, audit and business advisory advice and services. He was with PricewaterhouseCoopers from 1972 to 2006, serving as the firm’s Vice Chairman from 1994 to 1999 and as Chairman of its Global Technology and Infocomm practice from 1999 to 2006. Weaver is currently a director of AMN Healthcare, Inc. and WellCare Health Plans, Inc. He also served as a director of Gateway, Inc. from 2006 to 2007 and as a director of Idearc Media from 2006 to 2009. Weaver has served as a director of Unisys since 2010 and is Chairman of the Board and chair of the Audit and Finance Committee. Weaver’s experience in leadership and governance roles within PricewaterhouseCoopers, his position as head of the firm’s global technology practice and his years of experience providing audit and advisory services to a number of the world’s largest multinational companies make him particularly suited to be Chairman of Unisys and chair of the Audit and Finance Committee. In addition, his service on other boards and committees, including as chairman of the audit committees of AMN Healthcare and WellCare Health Plans, and as a member of the compensation committee of WellCare, gives him valuable knowledge and perspective.
Follow Paul Weaver:
About : WellCare provides government-sponsored managed care services to families, seniors, and those with complex medical needs.
Vangelis Vergetis
Co-Founder & Executive Director of Intelligencia
Vangelis is working on the intersection of data science, technology, and healthcare. In 2017 he co-founded Intelligencia, a company that uses AI to assess and minimize the risk of drug development. Prior to that he was a management consultant for more than 12 years – at both McKinsey and Hakluyt – advising healthcare clients and investors on a variety of topics, including digital technologies, clinical development and early commercialization. Outside of Intelligencia, Vangelis is a board member and member of the Executive Committee of the Alliance for Artificial Intelligence in Healthcare (AAIH), serves on the Dean’s Advisory Council for Cornell’s faculty of Computing & Information Science (CIS), and is an advisor and investor in technology companies in both the US and Europe. He holds a BS and PhD in Computer Science and Electrical Engineering.
Follow Vangelis Vergetis:
About Intelligencia: Intelligencia is a SaaS company that applies machine learning to assess and mitigate the risk in clinical development strategy/design.
Dimitrios Skaltsas
Co-Founder, Executive Director of Intelligencia
Dimitrios has led McKinsey’s team for big data & AI applications in R&D for life sciences, and has built SaaS products focusing on clinical development. He serves as an advisor, and has also invested, in several technology companies with a focus on big data. He holds an MBA from INSEAD, where he is also currently an Executive in Residence for AI/ Digital.
Follow Dimitrios Skaltsas:
About INSEAD, Intelligencia: Intelligencia is a SaaS company that applies machine learning to assess and mitigate the risk in clinical development strategy/design.
Russell Fowles
Director of Technical Operations of TrialSpark
Russell Fowles is the Director of Information Technology at [Oscar Insurance](https://www.crunchbase.com/organization/oscar), a health insurance company that employs technology, design, and data to humanize health care. He was previously lead of IT at the same company. Fowles also worked as an IT Technician and Systems Engineer at both Spotify and adMarketplace.
Follow Russell Fowles:
About TrialSpark: TrialSpark is a technology company that helps bring treatments to patients faster by reimagining how clinical trials are run.
Chocko Valliappa
Chief Executive Officer & Managing Director of Vee Technologies
Chocko Valliappa comes from a family of entrepreneurs, pioneering India’s growth in textiles, agriculture, plantations and more. Recognizing the importance of new technology, he founded the Valliappa Software Tech Park launching Oracle, CISCO and VeriFone in 1995.
Follow Chocko Valliappa:
About HireMee, SonaYukti, Vee Create, Vee FnA, Vee Protect, Vee Technologies, Vee Track: Vee Technologies is a transaction services company delivering total back-office processing solutions.
Richard Sackler
Director Purdue Pharma of Purdue Pharma
Richard Sackler is Member of Scientific Advisory Board at Kolltan Pharmaceuticals. Richard S. Sackler, Ph.D., M.D. served as the President of Purdue Pharma L.P. (Formerly, Purdue Frederick). Sackler serves as Co-chairman of Purdue Pharma.Sackler serves as a Member of Scientific Advisory Board at Kolltan Pharmaceuticals, Inc. Sackler serves as a Member of Scientific Advisory Board at Verastem, Inc. Sackler is an Adjunct Professor of Genetics at Rockefeller University.
Follow Richard Sackler:
About Purdue Pharma: Purdue Pharma L.P., a pharmaceutical company committed to improving patients’ lives and serving the healthcare community.
Batool Hassan
Director, Acumen Academy of Acumen
Batool initially joined Acumen Fund in the Pakistan office as a Knowledge and Communications Consultant working on various insight pieces and knowledge sharing initiatives around the Pakistan investments. She is now working as the Pakistan Business Development Associate managing fundraising and communications initiatives. Prior to joining Acumen Fund in Pakistan, she worked in the US in the consumer banking sector and has experience consulting in microfinance. Batool holds a Masters of International Affairs in Economic Development from the School of International Affairs, Columbia University.
Follow Batool Hassan:
About Acumen: Acumen is a non-profit venture fund that uses entrepreneurial approaches to solve the problems of global poverty.
Catherine Casey Nanda
Director, Acumen America of Acumen
Follow Catherine Casey Nanda:
About Acumen: Acumen is a non-profit venture fund that uses entrepreneurial approaches to solve the problems of global poverty.
Duncan Onyango
East Africa Director of Acumen
Follow Duncan Onyango:
About Acumen: Acumen is a non-profit venture fund that uses entrepreneurial approaches to solve the problems of global poverty.
Yasmina Zaidman
Director of Communications & Strategic Partnerships of Acumen
Follow Yasmina Zaidman:
About Acumen: Acumen is a non-profit venture fund that uses entrepreneurial approaches to solve the problems of global poverty.
Claudia Barrera
Worldwide Director, Global Digital Applications of Colgate Palmolive
Follow Claudia Barrera:
About Colgate Palmolive: Colgate-Palmolive is a consumer products company that produces, distributes, and provides household, healthcare, and personal products.
Gary Binstock
Tech Scouting: Director of Technology- Innovation and Alliances of Colgate Palmolive
Current Position at Colgate-Palmolive Director of Innovation focused on incubating new products and processes within the company with a focus on external partnerships. Recently launched first connected product at CP, a “Smart” Electric Toothbrush on sale exclusively at Apple. Incubating other Direct to Consumer and eCommerce products and distribution models within the company. As a member of the Global Engineering team I am working to identify and progress new innovation, IOT, and Factory of the Future initiatives. These technologies include the use of Wearables, Augmented Reality, 3D printing, machine learning and predictive analytics. Colgate is also rapidly adopting high speed automation and robotics to improve efficiencies and lower costs across the supply chain. Key role is to identify external partners including startups and academia to explore, develop, and test forward thinking technologies. We are a core member of the MIT Media Lab and Industrial Liason Program.
Follow Gary Binstock:
About Colgate Palmolive, Colgate Palmolive: Colgate-Palmolive is a consumer products company that produces, distributes, and provides household, healthcare, and personal products.
Rahul Tyagi
WW Director – Analytics CoE of Colgate Palmolive
Rahul Tyagi is the WW Director – Analytics CoE at Colgate-Palmolive.
Follow Rahul Tyagi:
About Colgate Palmolive: Colgate-Palmolive is a consumer products company that produces, distributes, and provides household, healthcare, and personal products.
Bethany Salmon
Senior Director, Product Management of Bigfoot Biomedical
Follow Bethany Salmon:
About Bigfoot Biomedical: Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Julia Morton
Senior Director, Customer Success of Flatiron Health
Julia leads the Customer Success function at Flatiron Health. The Flatiron team is building a disruptive, oncology-specific software platform that connects cancer centers across the world on a common technology infrastructure to address key healthcare challenges, dramatically improving treatment and accelerating research. Julia’s team is responsible for helping oncologists be successful on Flatiron’s software and partnering with customers to achieve their strategic objectives around practice sustainability and growth. The Customer Success team delivers Account Management, Customer Support, Technical Support Engineering, Communications and Training & Content services to oncology practices nationwide. Prior to joining Flatiron, Julia led the Physician Onboarding function at ZocDoc, and worked as a consultant to healthcare and technology clients growing their businesses and improving customers’ experience. She holds a BA and an MBA from Harvard.
Follow Julia Morton:
About Flatiron Health: Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient.
Evan Estola
Director of Engineering of Flatiron Health
Follow Evan Estola:
About Flatiron Health: Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient.
Lesley Plotkin
Director, Research Marketing of Flatiron Health
Follow Lesley Plotkin:
About Flatiron Health, Flatiron Health, Flatiron Health: Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient.
Carlos Aguilar
Director, Forward Deployed Engineering of Flatiron Health
Director, Forward Deployed Engineering at Flatiron Health.
Follow Carlos Aguilar:
About Flatiron Health: Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient.
Nathaniel Brown
Director of Product Marketing and Strategy of Flatiron Health
Nathaniel Brown is the director of product marketing and strategy at Flatiron Health.
Follow Nathaniel Brown:
About Flatiron Health: Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient.
Laura Palmisano
Physician Associate, PA Director and Lead Trainer of Schweiger Dermatology
Laura Palmisano is a licensed and certified Physician Assistant, a member of the American Academy of Physician Assistants, Society of Dermatology Physician Assistants, the New York Society of Dermatology PA’s, and is board certified through the NCCPA. She graduated from Sacred Heart University with a B.S. in Science with a Biology and Pre-Medicine Major, and received her Physician Assistant degree from Lenox Hill Hospital/Pace University PA Program, with Cum Laude honor. Laura Palmisano has been practicing in the Dermatology field for more than eight years, specializing in both medical and cosmetic dermatology with focus in laser technology and injectables. She has given Dermatological lectures and is a clinical preceptor for the Lenox Hill Hospital/Pace University PA Program. Ms. Palmisano has been chosen by Allergan, as a speaker and trainer for Doctors and Physician Extenders in the United States on Botox, Juvederm XC and Latisse. Laura Palmisano plays an active role in research as a Sub Investigator in numerous clinical trials on lasers, injectables and skincare. Laura Palmisano has been published in the Journal of Cosmetic Dermatology, the Aesthetic Surgery Journal and Cosmetic Dermatology of the Aging Face published in Clinics in Dermatology.
Follow Laura Palmisano:
About Allergan, Schweiger Dermatology: Schweiger Dermatology is a full service cosmetic & general dermatology.
Robb Knie
CEO, President & Director of Hoth Therapeutics
Mr. Knie has served as President and Chief Executive Officer and as a director of the Company since May 2017. Mr. Knie served as the President of Lifeline Industries Inc. since its inception in 1995. From 2002 to 2010 he was a Semiconductor Analyst for PAW Partners. From 1993 until 1995, Mr. Knie served as Northeast Regional Manager of American Express Financial Advisors. Mr. Knie has served as a board member for NASDAQ-listed companies. He has been featured on CNBC, Bloomberg, The Wall Street Journal and Forbes Magazine as an Independent Equity Analyst. Mr. Knie has over 20 years of equity markets experience. Mr. Knie has been a member of the American Chemical Society, Institute of Electrical and Electronics Engineers, as well as The National Alliance for Youth Sports.
Follow Robb Knie:
About Hoth Therapeutics: Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders.
Lorne Taichman
Director of Science & Technology of Windham Venture Partners
Follow Lorne Taichman:
About Windham Venture Partners: Founded in 2006, Windham is a New York City based venture capital firm focused on healthcare, with a particular emphasis on medical
Benjamin Wolin
Member of the Board of Directors of Diplomat Pharmacy
Benjamin Wolin is currently the Lead Independent Director for Diplomat Pharmacy (NYSE: DPLO), the nation’s largest independent specialty pharmacy. Prior to Diplomat, Wolin co-founded and was CEO of Everyday Health (NYSE: EVDY). As CEO since EVDY’s inception in 2002, Wolin oversaw the company from an idea, through numerous financings, an IPO and its eventual sale for ~$500M in 2016. Today, EVDY is still the leading digital marketing and communication platform for consumers, doctors, hospitals and the marketers that want to influence healthcare decision making. When Wolin left EVDY, the company was generating more than $275M/year in revenue and was working with every major healthcare company in the US. Wolin also currently advises several private companies in the digital, marketing and healthcare industries. Wolin has been recognized for his leadership and entrepreneurism by numerous publications and conferences.
Follow Benjamin Wolin:
About Covetrus, Everyday Health: Diplomat is a nationally recognized specialty pharmacy, and here, we offer a special kind of care.
Denny Moynihan
Senior Director of Quest Diagnostics
Denny Moynihan is a senior director at Quest Diagnostics.
Follow Denny Moynihan:
About Quest Diagnostics: Quest Diagnostics is a clinical laboratory that offers diagnostic testing, services, and information.
Rolf Classon
Member of the Board of Directors of Fresenius Medical Care
Rolf Classon has been a board member since August 2014. From October 2002 until his retirement in July 2004, Mr. Classon was Chairman of the Executive Committee of Bayer HealthCare AG, a subsidiary of Bayer AG. He served as President of Bayer Diagnostics from 1995 and 2002 and as Executive Vice President of Bayer Diagnostics from 1991 to 1995. Prior to 1991, Classon held various management positions with Pharmacia Corporation. From April 2005 to January 2015, Classon served as Chairman of the Board of Directors of Auxilium Pharmaceuticals, Inc. and as Vice Chairman from March 2005 to April 2005. Classon also currently serves as Chairman of the Board of Directors of Hill-Rom Corporation, where he also served as interim chief executive officer from May 2005 until March 2006. Classon currently serves as Chairman of the Board of Directors of Tecan Group Ltd. and as a member of the Board of Directors of Fresenius Medical Care. Classon previously served as a director of Millipore Corporation from December 2005 until July 2010, Prometheus Laboratories Inc. from September 2004 until 2010 and Enzon Pharmaceuticals Inc. from January 1997 until 2011. Classon received his Chemical Engineering Certificate from the Gothenburg School of Engineering and a Business Degree from the Gothenburg University.
Follow Rolf Classon:
About : Fresenius Medical Care is a healthcare company that provides dialysis treatment for those with chronic kidney diseases.
Adam Hanina
Co-Founder, Board Director of AiCure
Adam Hanina is CEO and co-founder of AiCure. He has been a strategist in healthcare software delivery for over fifteen years and holds over a dozen patents in his name. Prior to AiCure, he helped further develop Cerner Corporation’s European strategy and was a Visiting Fellow of eHealth at Imperial College in London, UK. Mr. Hanina has spoken extensively on the topic of healthcare innovation and has acted as a subject-matter expert on medication adherence technologies for the National Institutes of Health (NIH). He is currently a principal investigator for multiple NIH innovation grants. He holds an MBA from the Wharton School of Business.
Follow Adam Hanina:
About AIC Innovations Group, AiCure: AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.
Andrew Price
Co-Founder/Director of Outreach of Unite Us
Follow Andrew Price:
About Decisive Point, Unite Us: Unite Us provides a collaboration and coordination software, streamlining the delivery of health and social services.
Darren Sherman
President, Chief Operating Officer, Director and Founder of Orchestra BioMed
Darren Sherman is a Managing Partner of Orchestra. He is also Chief Technical Officer of Accelerated Technologies, Inc. (ATI) as well as Chief Executive Officer of Caliber Therapeutics, Inc., an OMV II Fund Portfolio Company. He has over 17 years of management and entrepreneurial experience in the medical technology industry spanning interventional cardiology, cardiac electrophysiology, sudden cardiac death, stroke, and neurovascular therapies. He currently serves as a director of Caliber Therapeutics and Vivasure Medical. Prior to joining Orchestra, Mr. Sherman held various positions in executive management for Cordis Neurovascular (CNV), a Johnson & Johnson company, including Executive Director R&D and Director of Strategic Marketing for stroke products. He had worldwide responsibility for all neurovascular R&D and global strategic marketing responsibilities for the Stroke franchise, including budgets, portfolio of products and strategic planning. Mr. Sherman made significant contributions to the design and commercialization of a series of key products including the Enterprise Vascular Reconstruction Device and the Orbit Embolic Coil as well as directed the filing of over 100 patents. Prior to joining CNV, Mr. Sherman played an integral role in the formation and development of Revivant Corp (acquired by Zoll) while working with Thomas J. Fogarty, MD at Fogarty Engineering. He was Revivant’s first employee and managed the design, development, and testing of the AutoPulse device from concept through market introduction. In addition to the R&D related activities, Mr. Sherman supported the clinical research, marketing, and intellectual property efforts. The AutoPulse is a lightweight, portable tool replacing the need for manual chest compressions during cardio-pulmonary resuscitation (CPR) for patients suffering from sudden cardiac arrest. Prior to Revivant, Mr. Sherman held positions in research and development for Cardiac Pathways Corp., prior to its acquisition by Boston Scientific, and Baxter Healthcare. In each of these companies, he participated in the creation, development and launch of products. Mr. Sherman has authored 45 U.S. patents with an additional 58 published applications. He earned a BS degree in Bioengineering from the University of California, San Diego.
Follow Darren Sherman:
About Orchestra BioMed, Orchestra Medical Ventures: Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
Meryl Natow
Co-Founder, Creative Director of Chirps Chips (Six Foods)
Follow Meryl Natow:
About Chirps Chips (Six Foods): Chirps Chips is a creating edible insect foods for healthyeating and sustainability.
Director, Digital Products & Strategy of Cancer Treatment Centers of America
Follow Kanav Jain:
About Cancer Treatment Centers of America: CTCA has been helping patients win the fight against cancer using advanced technology and a personalized approach.
Jacob Agris
Director Global Clinical Development of Bayer HealthCare
Follow Jacob Agris:
About Bayer HealthCare: Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.
J. Michael McFarland
Group Director, CAD Veterinary Operations of Zoetis India Ltd
J. Michael McFarland is Group Director, CAD Veterinary Operations @ Zoetis.
Follow J. Michael McFarland:
About Zoetis India Ltd: Zoetis provides healthcare services for animal.
Vinnie Dam
Co-Founder & Director of Pharmacy of Mixlab
Vinnie Dam is a Co-Founder and Director of Pharmacy at Mixlab.
Follow Vinnie Dam:
About Mixlab: Mixlab is the best-in-class pet pharmacy that partners with veterinarians.
Michael Goldstein
Member of the Board of Directors of Option Care Health
Michael Goldstein, 74, has been a director since May 2015. Goldstein currently serves as a director and Chairman of the Audit Committees of Pacific Sunwear of California, Inc., a publicly traded retail clothing company, and Teladoc, Inc., a publicly traded provider of telehealth services. Since 2011, Goldstein has served as a global senior advisor of Jefferies & Company, Inc., an investment banking firm. From 2002 to 2012, he served as a director and Chairman of the Audit Committee of 4Kids Entertainment, Inc., an entertainment merchandise licensing company. From 2005 to 2012, Goldstein served as a director, Chairman of the Nominating and Governance Committee and as a member of the Audit Committee and the Mergers and Acquisitions Committee of Medco Health Solutions, Inc., a pharmacy benefits management company. Goldstein previously held senior management positions in the retail industry, serving as Chief Executive Officer of Toys “R” Us, Inc., a toy retailer (“TOYS”), from 1994 to 1998, and then as TOYS’ Acting Chief Executive Officer from 1999 to 2000. He also served as the Chief Financial Officer of TOYS and as Senior Executive Vice President of Operations and Finance of Lerner Stores Corporation, a chain department store retailer. Goldstein began his career as an accountant at Ernst & Young, where he served as an audit partner for six years. We believe that Goldstein’s extensive finance and business operations background, as well as his prior experience serving on the boards of directors of public companies, are relevant to his service on the Board.
Follow Michael Goldstein:
About Jefferies: Option Care Health is a provider of comprehensive, cost-effective pharmaceutical and home care solutions.
Brad Warsh
Creative Director and Co-Founder of WAVE Meditation
Brad Warsh is the creative director and co-founder at WAVE.
Follow Brad Warsh:
About WAVE Meditation: WAVE Meditation is a music-guided at-home meditation app for breath, body and beat daily rituals.
Richard Gonzalez
Director of Sales of Drunk Elephant
Follow Richard Gonzalez:
About Drunk Elephant: Drunk Elephant is a non-toxic skin care brand.
Marc Capra
Co-Founder & Creative Director of Sol de Janeiro
Marc Capra is a Co-Founder and Creative Director at Sol de Janeiro.
Follow Marc Capra:
About Sol de Janeiro: Sol de Janeiro is a cosmetics company that celebrates everything that is unique and joyful.
Rebecca Silver
Senior Director of Marketing of Kindbody
Rebecca Silver is a senior director of marketing at Kindbody.
Follow Rebecca Silver:
About Kindbody: Kindbody is a health and technology company providing fertility, gynecology, and family-building care.
Mike Skarlinski
Director, Data Science and Data Platforms of WW International
Michael Skarlinski is the Director, Data Science and Data Platforms at WW (formerly Weight Watchers).
Follow Mike Skarlinski:
About WW International: WW International is a global wellness company and the world’s leading commercial weight management program.
Carl Anderson
Director & Data Science of WW International
Carl Anderson is the Director of Data Science at Warby Parker in New York overseeing data engineering, data science, supporting the broader analytics org, and creating a data-driven organization. He has had a broad-ranging career, mostly in scientific computing, covering areas such as healthcare modeling, data compression, robotics, and agent based modeling. He holds a Ph.D. in mathematical biology from the University of Sheffield, UK. He is the author of “Creating a Data-Driven Organization.
Follow Carl Anderson:
About WW International: WW International is a global wellness company and the world’s leading commercial weight management program.
Howard Reid
Director of Marketing, Rheumatology of Janssen
Follow Howard Reid:
About Janssen: Janssen is the pharmaceutical arm of Johnson & Johnson.
Richard Schnall
Board of Director of Envision Healthcare
Rick Schnall is the Partner at Clayton Dubilier & Rice.
Follow Richard Schnall:
About CD&R LLP: Envision Healthcare offers array of healthcare-related services to consumers, hospitals.
James Shelton
Board of Director of Envision Healthcare
James D. Shelton was elected to Envision’s Board of Directors in May 2015. Mr. Shelton served as Chairman, Chief Executive Officer and President of Triad Hospitals, Inc., from 1999 until its sale in 2007. Prior to his leadership at Triad Hospitals, Mr. Shelton held numerous executive positions at Columbia/HCA Healthcare Corporation, serving as President of the Pacific Group from 1998 to 1999 and President of the Central Group from 1994 to 1998. Mr. Shelton serves as Chairman of the Board of Directors of Omnicare, Inc., and also was interim Chief Executive Officer of Omnicare from July through December 2010. He also is a member of the Board of Directors of Ventas, Inc. Mr. Shelton earned a bachelor’s degree from Louisiana State University and a Master of Science degree in public administration from University of Missouri-Columbia.
Follow James Shelton:
About : Envision Healthcare offers array of healthcare-related services to consumers, hospitals.
Carl Eppers
Director of Employer Partnerships of Baby Doctor, Inc.
Follow Carl Eppers:
About Baby Doctor, Inc.: Baby Doctor, Inc. was a healthcare startup that offered pediatric services on demand
Emily Rose Prats
Marketing Director of Baby Doctor, Inc.
Emily Rose is a digital marketer with years of start-up and small business experience. An NYU graduate, she is now a brand storyteller specializing in strategy, content creation, social media, influencer relations, partnership building, and event marketing. She’s currently with tech start-up Baby Doctor after her efforts yielded the 200% year-over-year online sales growth at her last company.
Follow Emily Rose Prats:
About Baby Doctor, Inc.: Baby Doctor, Inc. was a healthcare startup that offered pediatric services on demand
Murray Aitken
Executive Director of IQVIA
Follow Murray Aitken:
About Health IQ, IQVIA: IQVIA is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry.
David Bell
Chairman of the Board of Director of The National Forest Foundation
David Bell joined the m6d board in June 2011. He is the former President and Chief Executive Officer of Interpublic Group, Chairman and Chief Executive Officer of True North Communications and President of Bozell Group. Over the past seven years, he has been a board member and/or trusted advisor to many companies, including Google, AOL, Freedom Group, Resonate Networks, Primatech, DoubleVerify, Warnaco Group and Vizu. He is Chairman of The National Forest Foundation, and has served as Chairman of the American Association of Advertising Agencies, two-time Chairman of the American Advertising Federation, Chairman of The Advertising Council, Chairman Emeritus of the Advertising Education Foundation and Chairman of PRO-AD PAC. He served as a Trustee of Macalester College, where he graduated in 1965.
Follow David Bell:
About Creative Realities, Pegasus Capital, Twaitter.com: The National Forest Foundation helps raise money to take care of the many forests and helps protect them.
Isaac Wagner
Director, Strategy Analytics of Memorial Sloan – Kettering Cancer Center
Isaac Wagner is the Director, Strategy Analytics at Memorial Sloan Kettering Cancer Center.
Follow Isaac Wagner:
About Memorial Sloan – Kettering Cancer Center: Memorial Sloan – Kettering Cancer Center develops health-related apps and educational programs for mobile platforms.
Drennon Kimpton
Editorial Director of Grit Magazine of UCSF health
Follow Drennon Kimpton:
About UCSF health: UCSF health offers healthcare services in the areas of cancer, heart disorders, neurological disorders, organ transplants, and more.
Baris Yagci
Director of Device R&D of Clarapath
Baris Yagci is the Director of Device R&D at Clarapath.
Follow Baris Yagci:
About Clarapath: We are a medical robotics company developing the SectionStar, a platform to mimic the human histotechnician.
Kavita Sethi
Director of Finance of Clarapath
Kavita Sethi is the Director of Finance at Clarapath.
Follow Kavita Sethi:
About Clarapath: We are a medical robotics company developing the SectionStar, a platform to mimic the human histotechnician.
Kelly Grimshaw
Board of Directors of Médecins Sans Frontières
Kelly Grimshaw joined MSF in 1999, establishing a Tuberculosis program in Turkmenistan. She has since worked as a Nurse Practitioner and Project Coordinator and China, Sierra Leone, Indonesia, and Zambia assisting those affected by civil and ethnic conflicts as well as the HIV pandemic. Kelly also provided further assistance and program oversite as Medical Coordinator in Angola, Liberia, Ivory Coast, and Nigeria with responses to cholera, Marburg Hemorrhagic Fever, meningitis, and measles outbreaks. In the US she has volunteered her services to the MSF-USA’s Speaker’s Bureau throughout the country and Refugee Camp in the Heart of the City exhibits. She currently works in nursing education.
Follow Kelly Grimshaw:
About : MSF delivers emergency medical aid to people affected by armed conflict, epidemics, healthcare exclusion, and natural or man-made disasters.
Charles Koob
Member of the Board of Directors of MiMedx Group
Charles Koob is a Member of the Board of Directors at MiMedx. Charles joined the law firm of Simpson Thacher & Bartlett, LLP in 1970 and became a Partner in 1977. Charles retired from that firm on January 1, 2007 but remains of counsel. While at that firm, Charles was the Co-Head of the Litigation Department and served on the firm’s executive committee. Charles specializes in competition, trade regulation and antitrust issues. Throughout his 37-year tenure, he has represented clients before the Federal Trade Commission, the Antitrust Division of the Department of Justice and numerous state and foreign competition authorities. Charles’ resume includes the representation of Virgin Atlantic Airways, Archer Daniels Midland, and Kohlberg Kravis Roberts and Co. Charles received his B.A. degree from Rockhurst College in 1966 and his J.D. from Stanford Law School in 1969. In addition to his practice, Charles is a Trustee of the Natural Resources Defense Council, is President of the Yellowstone Park Foundation and is the Co-Chair of the Steering Committee for the current campaign for Stanford Law School. Charles is the brother of Dr. Thomas J. Koob, Chief Scientific Officer of MiMedx Group.
Follow Charles Koob:
About : MiMedx Group provides regenerative biologics utilizing human placental tissue allografts with patent-protected processes.
Bruce Hack
Member of the Board of Directors of MiMedx Group
Bruce Hack is a Member of the Board of Directors at Overwolf since since April 2013. Bruce was Vice Chairman of the Board of Directors and Chief Corporate Officer of Activision Blizzard until 2009. Prior to that, Bruce was Chief Executive Officer of Vivendi Games, from 2004 to 2008, Vice Chairman of the Board of Directors of Universal Music Group, from 1998 to 2001 and Chief Financial Officer of Universal Studios, from 1995 to 1998. From 1982-1994, Bruce held several positions at The Seagram Company, including: Assistant to the Executive Vice President, Sales and Marketing for Seagram USA; Director, Strategic Planning, at The Seagram Company Ltd.; and Chief Financial Officer of Tropicana Products, Inc. Prior to this, Bruce was a trade negotiator for the U.S. Treasury. Bruce earned a B.A. degree at Cornell University and an MBA in Finance at the University of Chicago.
Follow Bruce Hack:
About : MiMedx Group provides regenerative biologics utilizing human placental tissue allografts with patent-protected processes.
Michael Schmertzler
Member of the Board of Directors of Cytokinetics
Michael Schmertzler has served as a member of PTC’s board of directors since August 2001 and as the Chairman of our board of directors since November 2004. From 2008 to 2012, Michael Schmertzler served as Chief Executive Officer and a director of Kolltan Pharmaceuticals, Inc., a biotechnology company. Since 2001, Michael Schmertzler has served as a Managing Director of Aries Advisors, LLC, the sub-advisor to Credit Suisse First Boston Equity Partners, L.P., a private equity fund, and the Chair of the investment committee. From 1997 to 2001, Michael Schmertzler was Co-Head of United States and Canadian Private Equity at Credit Suisse First Boston, an investment banking company. Prior to 1997,Michael Schmertzler held various management positions with Morgan Stanley and its affiliates, including President of Morgan Stanley Leveraged Capital Funds and head of Morgan Stanley’s biotechnology pharmaceuticals group, and was Managing Director and Chief Financial Officer of Lehman Brothers Kuhn Loeb, an investment banking firm. Michael Schmertzler is currently a director of Lehman Commercial Paper Incorporated, a liquidating postbankruptcy subsidiary of Lehman Brothers Holdings, Incorporated. Mr. Schmertzler previously served as a director of Cytokinetics, Incorporated. Since 1978, he has been an Adjunct Professor at Yale University. Michael Schmertzler received a B.A. from Yale College in Molecular Biophysics and Biochemistry, History and City Planning and an M.B.A. from the Harvard Business School.
Follow Michael Schmertzler:
About : Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Frederico Lourenco
Senior Director, Corporate Development and Strategy of Rubius Therapeutics
Follow Frederico Lourenco:
About Rubius Therapeutics: Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.
Jim Warner
Member of the Board of Directors of Talix
James Warner has served as a member of our board of directors and as chairman of the compensation committee since February 2013, and as our lead independent director since December 2013. Since January 2009, he has been a Principal of Third Floor Enterprises, an advisory firm specializing in digital marketing and media. From January 2000 until December 2008, Warner served in various leadership roles at aQuantive Inc., including as Executive Vice President at Razorfish Inc. (formerly Avenue A), which was acquired by Microsoft Corporation in August 2007. Prior to aQuantive, he held leadership positions at HBO, CBS and Primedia. James is also a member of the board of directors for Merkle, Inc., Invision, Inc., Zoom, Inc. and Healthline Networks, Inc. From 2011 to 2012, James served as a member of the board of directors of MediaMind, Inc. James received a Bachelor of Arts degree in American Studies from Yale University and a Master in Business Administration from Harvard Business School. The board of directors believes that James’s experience in the consumer and digital marketing and media industries allows him to make valuable contributions to the board of directors.
Follow Jim Warner:
About : Talix provides risk adjustment, quality and oncology solutions for value-based care.
